Restoring Natural Killer Cell Immunity against Multiple Myeloma in the Era of New Drugs.
about
MICA-129 Dimorphism and Soluble MICA Are Associated With the Progression of Multiple Myeloma.Osteoclast Immunosuppressive Effects in Multiple Myeloma: Role of Programmed Cell Death Ligand 1Mechanisms of NK Cell Activation and Clinical Activity of the Therapeutic SLAMF7 Antibody, Elotuzumab in Multiple Myeloma
P2860
Restoring Natural Killer Cell Immunity against Multiple Myeloma in the Era of New Drugs.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Restoring Natural Killer Cell Immunity against Multiple Myeloma in the Era of New Drugs.
@en
Restoring Natural Killer Cell Immunity against Multiple Myeloma in the Era of New Drugs.
@nl
type
label
Restoring Natural Killer Cell Immunity against Multiple Myeloma in the Era of New Drugs.
@en
Restoring Natural Killer Cell Immunity against Multiple Myeloma in the Era of New Drugs.
@nl
prefLabel
Restoring Natural Killer Cell Immunity against Multiple Myeloma in the Era of New Drugs.
@en
Restoring Natural Killer Cell Immunity against Multiple Myeloma in the Era of New Drugs.
@nl
P2093
P2860
P356
P1476
Restoring Natural Killer Cell Immunity against Multiple Myeloma in the Era of New Drugs
@en
P2093
Benedetto Bruno
Deena Mudawi
Gianfranco Pittari
Luisa Giaccone
Moreno Festuccia
P2860
P356
10.3389/FIMMU.2017.01444
P577
2017-11-07T00:00:00Z